Csaba Galambos, MD, PhD
Pediatric Pathology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Care Philosophy
I am dedicated to providing the highest quality, professional, and ethical care to all patients. I am a physician-scientist committed to a combined academic track of research and clinical service. I carry out my clinical responsibilities as a pediatric pathologist at Children’s Hospital Colorado, where I provide diagnostic expertise in pediatric surgical and autopsy pathology with subspecialty expertise in pediatric lung disease. I provide comprehensive diagnostic service for infants and children with pulmonary disease by coordinating multidisciplinary approach through The Breathing Institute, Department of Pediatric Surgery and Colorado Institute for Maternal and Fetal Health. I have a career-long passion for understanding the mechanisms of lung vascular development and related disorders in order to develop novel strategies that could lead to earlier diagnoses, prevention, and potential cures for infants and children with pulmonary vascular disease. I serve as a nationally and internationally recognized pediatric pulmonary pathology case consultant.
Specialties
- Pediatric Pathology ( 2003 )
- Anatomic and Clinical ( 2003 )
Education & Training
Graduate Schools
MD, University of Pecs (1992)
PhD, Semmelweis University (2008)
Residency Program
Saint Louis University School of Medicine Program (2002)
Fellowships
University of Washington Program (1997)
Children's Hospital/Harvard Medical School Program (2003)
Professional Memberships
American Thoracic Society, Member
Children Interstitial Lung Disease (ChILD) Research Cooperative, Advanced case reviewer
North American Vascular Biology Organization (NAVBO), Member
PPHNet (Pediatric Pulmonary Hypertension International Network, Member and Head of Pathology Committee
Pulmonary Pathology Society (PPS), Member
Society for Pediatric Pathology (SPP), Member
TBX4Life-- Global, Patient-oriented Research Initiative, Member and Head of Pathology Committee
The International Society for the Study of Vascular Anomalies (ISSVA), Member
United States and Canadian Academy of Pathology (USCAP), Member
Research & Grants
Grants
Molecular Pathomechanism of Alveolar Capillary Dysplasia (2008)
Role of Impaired Angiogenesis in the Pathogenesis of Severe Cardiopulmonary Disease in Children with Down Syndrome (2014)
Role of Anti-Angiogenic Factors in Cardiopulmonary Disease in Down Syndrome (2015)
Role of Pericytes and Platelet-Derived Growth Factor-Beta Signaling in the Pathogenesis of Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACD/MPV) (2015)
Recruitment of intrapulmonary bronchopulmonary anastomoses as a novel mechanism for sudden unexplained infant death (2017)
Overexpression of anti-angiogenic genes impairs lung development in Dp16 mice (2018)
Role of VEGF in Perinatal Hypertension (2019)
RCAN1-driven pulmonary endothelial cell dysfunction leads to pulmonary hypoplasia and pulmonary hypertension in Down syndrome (2019)
The role of serotonin signaling pathway in Alveolar Capillary Dysplasia (2019)
The Role of Bronchial Circulation in Pulmonary Hypertension (2022)
“Multidisciplinary Research Training Grant in Pediatric Pulmonary Vascular Disease (2022)
Abnormal HIF Signaling in Down Syndrome-Related Pulmonary Hypertension (2022)
information for referring providers
Referral Contact Phone
720-777-1234
Research Interest for Referring Providers
I am physician-scientist specializing in pulmonary vascular biology. My laboratory has made a number of original discoveries regarding lung development and associated disorders. My independently funded research programs represent new and independent paths of scientific investigation. I have maintained consistent funding support for my research efforts, including multiple peer-reviewed, competitive, government and private foundation grants. My overall academic goal is to build a bridge between the research bench and the bedside to develop therapies to treat or cure neonatal and pediatric lung disorders and to establish a laboratory with a focus on training physician-scientists committed to furthering this mission.